CRISPR Therapeutics AG (CRSP)

CRSP trades at $61.67, 6.3% above the near-term max pain of $58 expiring Oct 3, 2025 (5 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is falling across expirations ($40-$70), signaling increased put positioning or downside protection. Key magnetic zone at 50 where 4 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.

Max pain for CRSP shows a downward trend from 70 to 40, indicating bearish sentiment or hedging activity. The 56% spread signals divergent expectations across timeframes. Most levels below 61.67 may cap rallies. Strong magnetic level at 50 (4 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.